Rilas Technologies Announces Sponsorship at LabCentral, Fortifying Support for Biotech Innovation
Rilas Technologies, a Massachusetts-based and leading analytical chemistry CRO with a rich legacy of supporting the biotech industry since 2009, proudly announces its sponsorship of LabCentral, the premier launchpad for startup biotech companies in Cambridge, MA. This strategic partnership symbolizes a joint commitment to fostering innovation, collaboration, and the advancement of biotechnology. Leveraging its extensive experience, Rilas will provide a range of services and training initiatives tailored to meet the specific needs of the dynamic startup ecosystem within LabCentral.
Key Benefits of Rilas Technologies’ Sponsorship at LabCentral:
- Analytical Expertise: Rilas Technologies will directly consult with resident companies on techniques to fully utilize the numerous analytical chemistry and purification resources available at LabCentral.
- Data Ownership: With the know-how provided by Rilas Technologies, LabCentral companies can confidently generate their own chromatographic data, freeing them from the uncertainty and long lead times associated with reliance on overseas vendors.
- Accelerated timelines: By leveraging Rilas Technologies’ expertise to unlock the speed, throughput, and quality of chromatographic processes, LabCentral companies will be empowered to make informed go/no-go decisions in minutes or hours, not days or weeks.
In expressing enthusiasm about the partnership, Laszlo Varady, President & CEO of Rilas Technologies said, “We are thrilled about this general sponsorship opportunity with LabCentral. Rilas strongly believes in the power of collaboration and knowledge sharing. By supporting the vibrant community at LabCentral, we aim to contribute to the collective success of the biotech industry and push the boundaries of scientific discovery.”
Dr Johannes Fruehauf, Founder and President of LabCentral added: “As a partner of LabCentral, Rilas Technologies’ experience and leadership in the analytical chemistry space will help our residents accelerate their research as we collectively align on a mission to advance solutions to improve human health faster and more efficiently.”
This sponsorship reflects Rilas Technologies’ dedication to empowering the next generation of biotech innovators and underscores LabCentral’s commitment to providing startups with the resources and expertise needed for success.
For media inquiries or further information, please contact:
Julia Giessen
Director of Communications
781.281.0831 x 101
About Rilas Technologies
Rilas Technologies is a Massachusetts-based purification and analytical company that has been a trusted partner in the biotech industry since 2009. Committed to excellence, Rilas provides comprehensive support, innovative solutions, and a wealth of expertise to empower biotech companies in their pursuit of groundbreaking advancements.
About LabCentral
A private, non-profit institution, LabCentral was founded in 2013 as a launchpad for high potential life-sciences and biotech startups. Operating a total of 225,000 square-feet in the heart of Kendall Square in Cambridge, Mass., LabCentral offers fully permitted laboratory and office space for as many as 100 startups comprising approximately 1,000 scientists and entrepreneurs. More information is available at www.labcentral.org.
Note: This press release is accurate as of the date of issuance and is subject to change without notice.
